Search

Your search keyword '"Ansari, Aftab A."' showing total 80 results

Search Constraints

Start Over You searched for: Author "Ansari, Aftab A." Remove constraint Author: "Ansari, Aftab A." Publisher ovid technologies (wolters kluwer health) Remove constraint Publisher: ovid technologies (wolters kluwer health)
80 results on '"Ansari, Aftab A."'

Search Results

1. E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants

5. Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics

6. The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis

9. Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis

11. IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: Implications for therapy

12. Clonality, activated antigen-specific CD8+T cells, and development of autoimmune cholangitis in dnTGFβRII mice

13. Reply

14. Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis

15. Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice

16. Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis

17. The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17a deleted dominant negative form of transforming growth factor beta receptor type ii mice

18. Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis

19. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis

20. Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis

21. Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis

22. Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis

23. B cell depletion therapy exacerbates murine primary biliary cirrhosis

25. Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor β receptor II improves colitis but exacerbates autoimmune cholangitis

26. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor β receptor type II mice

29. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease

32. Adoptive transfer of CD8+ T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice

33. Natural killer T cells exacerbate liver injury in a transforming growth factor β receptor II dominant-negative mouse model of primary biliary cirrhosis

36. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis

38. IL-2 receptor α−/− mice and the development of primary biliary cirrhosis

42. Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis

45. Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC

46. Differential expression of intestinal trefoil factor in biliary epithelial cells of primary biliary cirrhosis

49. The SJL/J mouse is not a model for PBC

Catalog

Books, media, physical & digital resources